RE: No Profit data as usual22 Apr 2026 16:36
Well according to AI, the H1 2026 Financial report in June 2026 could see a catalyst for a re rating of THG shares. (Maybe??)
THG’s current market cap: the market is effectively treating THG's £1.1 billion revenue Beauty Division as a liability, rather than an asset.
If we look at the data as of April 2026, the disconnect is even sharper than it was last year.
The "Zero Value" Math
If we apply your logic and give THG Nutrition a conservative 1x sales multiple (which is arguably low given Myprotein's global dominance and recent 8.8% Q1 growth), the valuation breaks down like this:
THG Nutrition Revenue (FY25): ~£609m
Implied Value (1x Sales): ~£609m
Current THG Market Cap (April 2026): ~£647m
The Conclusion: At today's share price (approx. 39p–40p), once you account for the value of Myprotein, the market is valuing THG Beauty (£1.1bn revenue), the £80m VAT refund, the £102m cash from asset sales, and the entire Ingenuity platform at a combined total of just £38 million.
Why is Beauty "Invisible" to the Market?
Even with THG Beauty accelerating (up 5.8% in Q1 2026 with the US performance finally turning a corner), the valuation hasn't budged for three specific reasons:
The Margin Perception Gap: Applied Nutrition (APN) trades on high multiples because it boasts ~29% EBITDA margins. THG Beauty, while 10x larger than the likes of APN's NutritionBusiness, has historically operated on 4-5% margins. Investors are prioritizing "profitable scale" over "gross scale."
The Conglomerate "Fog": The market currently cannot see THG Beauty through the "smog" of the Ingenuity demerger and the group's historical debt. The £102m net cash gain from disposals like Claremont is being viewed by the City as "repair money" rather than "growth money."
The Ingenuity Anchor: Until the Ingenuity demerger is legally finalized (expected later in 2026), the Beauty division is still financially tethered to a tech platform that requires significant maintenance CapEx.
For the "sideways" pattern to break and for Beauty to finally be valued at even 0.5x sales (which would double the share price alone), three "Checkmate" moves are needed:
The Physical Cash: The £80m VAT refund and the £102m from disposals must move from "Expected" to "Cash on Balance Sheet" in the interim report.
The Demerger Execution: Once Ingenuity is a separate private entity, "RemainCo" (Beauty + Nutrition) becomes a simple, high-revenue retail business that is much easier for institutional funds to buy.
The "L'Oréal" Factor: Given that THG Beauty is currently being valued at nearly zero, the risk of a hostile takeover from a global beauty conglomerate grows every day the share price stays under 50p.
The business has "cleaned the house" and "stocked the cupboards," but the market is still refusing to come to the party until they see the actual bank statements for June 2026.
JAO Adyor!!!!!